Purpose
The purpose of this study is to classify and analyze the impact of antecedents studied in the extant literature on two levels of SME alliance performance – alliance-level and firm-level.
Design/methodology/approach
Using online databases and the bibliography section of the selected articles, 45 peer-reviewed studies specifically analyzing the impact of antecedents on the performance of SME alliances at the two levels were studied to gain insights.
Findings
The study differentiates between the impact of antecedents on the two levels of SME alliance performance, alliance-level and firm-level, and finds that certain antecedents, such as absorptive capacity, corporate entrepreneurship, control, network dimensions, partner opportunism and partner reputation, have a peculiar impact on a single level while other antecedents such as trust, commitment and cooperation, have an influence on performance at both levels. Also, the impact of these antecedents is hypothesized to be weak or strong, depending upon the results obtained by the papers in the review.
Research limitations/implications
In a first-of-its-kind approach, the paper provides a conceptual insight into the differentiating impact of antecedents on SME alliance performance at both levels, as opposed to the unitary analysis approach used in the extant literature. The model provided by the study can be used by researchers to gain a systematic understanding of how alliance outcomes are affected.
Practical implications
While the extant literature remains largely ambiguous on the role of antecedents causing variance in SME alliance outcomes, this paper serves to bridge this gap and enhance the understanding of practitioners by systematically analyzing how specific antecedents affect SME alliance performance at both levels.
Originality/value
As opposed to the unitary approach used in the extant literature, which does not differentiate between the two levels of SME alliance performance, this paper arranges and categorizes these studies based on the level at which alliance performance has been analyzed. Furthermore, the paper identifies the impact of antecedents at each level, thereby providing pioneering insights on understanding SME alliance outcomes.
PurposeThe objective of the study is to analyse the impact of research and development investment on the firm performance of “small” scale firms vis-a-vis “medium”-scale firms.Design/methodology/approachThe dataset comprised of a balanced panel of 486 research and development conducting Indian manufacturing small and medium enterprises, constructed for the period of 2006–2017. Fixed Effects, Random Effects Model and Hausmann test were used to analyse the determinants of firm performance in manufacturing small and medium enterprises in India.FindingsIt was found that from firms’ research and development (R&D) investments in terms of performance could be attained if simultaneously internationalisation and higher capital intensity could be achieved.Practical implicationsManagers could pay specific attention to the antecedents of firm performance and calibrate their R&D investment, internationalisation efforts and capital intensity simultaneously to achieve higher growth and productivity. For policymakers, the results provide an insight into how the firms in both categories could be differently incentivised, such that resources are better utilised.Originality/valueThe study analysed the determinants of firm performance in small and medium-sized firms at a disaggregate level as well as at a sectoral level using fixed effects, random effects and lagged effects to arrive at novel results, which have important implications for their competitiveness.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.